Valentina Roquemen-Echeverri, Clara Escorihuela-Altaba, Taisa Kushner, Peter G. Jacobs, Jose Garcia-Tirado, Clara Mosquera-Lopez
{"title":"Physiology-guided artificial intelligence digital twins for simulating glucose dynamics in type 2 diabetes","authors":"Valentina Roquemen-Echeverri, Clara Escorihuela-Altaba, Taisa Kushner, Peter G. Jacobs, Jose Garcia-Tirado, Clara Mosquera-Lopez","doi":"10.1016/j.bbe.2026.08.001","DOIUrl":null,"url":null,"abstract":"<div><div><strong>Background:</strong> Metabolic simulators help accelerate the development of diabetes technologies, but existing mechanistic models for type 2 diabetes (T2D) are difficult to individualize and provide limited explanation of the complex interplay between physiology and available treatments. <strong>Methods:</strong> First, we trained NeuralOGTT, a neural network state-space model that replicates glucose-insulin dynamics during the oral glucose tolerance test (OGTT) in T2D. Next, we determined the minimal model architecture using a variance-based sensitivity analysis. Finally, we created digital twins (DT-NeuralOGTT) by adding auxiliary sub-networks to the NeuralOGTT trained using individuals data from a free-living observational study (N=38, age: 50 ± 10 years; 27 females; 1 high risk of diabetes, 9 pre-T2D, and 28 T2D). We simulated study scenarios and assessed the digital twins ability to replicate real-world glucose outcomes: time in range (TIR,<span><math><mrow><mn>70</mn><mo>−</mo><mn>180</mn></mrow></math></span> mg/dL), time in tight range (TITR,<span><math><mrow><mn>70</mn><mo>−</mo><mn>140</mn></mrow></math></span> mg/dL), time below range (TBR, < 70 mg/dL), and time above range (TAR, > 180 mg/dL). <strong>Results:</strong> NeuralOGTT replicated glucose dynamics during OGTTs. Personalized DT-NeuralOGTT enabled generalization under free-living conditions across 12-h simulations, achieving simulated glucose outcomes that are statistically identical to observed outcomes: TIR: 91.8 (95% CI:82.2–96.0)% vs. 92.1 (95% CI:83.5–95.8)%, TITR: 56.0 (95% CI:36.6–77.4)% vs. 59.3 (95% CI:48.7–76.4)%, TAR: 6.3 (95% CI:1.6–15.8)% vs. 7.4 (95% CI:3.8–15.7)%, and TBR: 0.5 (95% CI:0.0–1.0)% vs. 0.1 (95% CI:0.1–0.2)%. <strong>Conclusion:</strong> NeuralOGTT models glucose–insulin dynamics using a structure that preserves explainability while requiring small amounts of training data. DT-NeuralOGTT incorporates individual variability to better capture dynamics in pre-T2D and T2D. Code available: <span><span>https://github.com/mosqueralopez/T2DSim_AI</span><svg><path></path></svg></span></div></div>","PeriodicalId":55381,"journal":{"name":"Biocybernetics and Biomedical Engineering","volume":"46 3","pages":"Pages 619-635"},"PeriodicalIF":4.9000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biocybernetics and Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0208521626000562","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Metabolic simulators help accelerate the development of diabetes technologies, but existing mechanistic models for type 2 diabetes (T2D) are difficult to individualize and provide limited explanation of the complex interplay between physiology and available treatments. Methods: First, we trained NeuralOGTT, a neural network state-space model that replicates glucose-insulin dynamics during the oral glucose tolerance test (OGTT) in T2D. Next, we determined the minimal model architecture using a variance-based sensitivity analysis. Finally, we created digital twins (DT-NeuralOGTT) by adding auxiliary sub-networks to the NeuralOGTT trained using individuals data from a free-living observational study (N=38, age: 50 ± 10 years; 27 females; 1 high risk of diabetes, 9 pre-T2D, and 28 T2D). We simulated study scenarios and assessed the digital twins ability to replicate real-world glucose outcomes: time in range (TIR, mg/dL), time in tight range (TITR, mg/dL), time below range (TBR, < 70 mg/dL), and time above range (TAR, > 180 mg/dL). Results: NeuralOGTT replicated glucose dynamics during OGTTs. Personalized DT-NeuralOGTT enabled generalization under free-living conditions across 12-h simulations, achieving simulated glucose outcomes that are statistically identical to observed outcomes: TIR: 91.8 (95% CI:82.2–96.0)% vs. 92.1 (95% CI:83.5–95.8)%, TITR: 56.0 (95% CI:36.6–77.4)% vs. 59.3 (95% CI:48.7–76.4)%, TAR: 6.3 (95% CI:1.6–15.8)% vs. 7.4 (95% CI:3.8–15.7)%, and TBR: 0.5 (95% CI:0.0–1.0)% vs. 0.1 (95% CI:0.1–0.2)%. Conclusion: NeuralOGTT models glucose–insulin dynamics using a structure that preserves explainability while requiring small amounts of training data. DT-NeuralOGTT incorporates individual variability to better capture dynamics in pre-T2D and T2D. Code available: https://github.com/mosqueralopez/T2DSim_AI
期刊介绍:
Biocybernetics and Biomedical Engineering is a quarterly journal, founded in 1981, devoted to publishing the results of original, innovative and creative research investigations in the field of Biocybernetics and biomedical engineering, which bridges mathematical, physical, chemical and engineering methods and technology to analyse physiological processes in living organisms as well as to develop methods, devices and systems used in biology and medicine, mainly in medical diagnosis, monitoring systems and therapy. The Journal''s mission is to advance scientific discovery into new or improved standards of care, and promotion a wide-ranging exchange between science and its application to humans.